Furthermore, in non‐Hippo pathway‐dependent YAP activation, RASSF1A expression regulates TGF‐β‐induced YAP1/SMAD2 interaction, exerting a cancer‐inhibiting effect [240]. Here, YAP1 is linked to cancer.